Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Antibacterial efficacy and cytotoxicity of low intensity direct current activated silver-titanium implant system prototype.

Tan Z, Havell EA, Orndorff PE, Shirwaiker RA.

Biometals. 2017 Feb;30(1):113-125. doi: 10.1007/s10534-017-9993-1. Epub 2017 Jan 16.

PMID:
28093655
2.

Listeria monocytogenes wall teichoic acid decoration in virulence and cell-to-cell spread.

Spears PA, Havell EA, Hamrick TS, Goforth JB, Levine AL, Abraham ST, Heiss C, Azadi P, Orndorff PE.

Mol Microbiol. 2016 Sep;101(5):714-30. doi: 10.1111/mmi.13353. Epub 2016 Mar 10.

3.

Extrauterine listeriosis in the gravid mouse influences embryonic growth and development.

Suyemoto MM, Hamrick TS, Spears PA, Horton JR, Washington IM, Havell EA, Borst LB, Orndorff PE.

PLoS One. 2013 Aug 14;8(8):e72601. doi: 10.1371/journal.pone.0072601. eCollection 2013.

4.

In vitro properties of a Listeria monocytogenes bacteriophage-resistant mutant predict its efficacy as a live oral vaccine strain.

Spears PA, Suyemoto MM, Hamrick TS, Wolf RL, Havell EA, Orndorff PE.

Infect Immun. 2011 Dec;79(12):5001-9. doi: 10.1128/IAI.05700-11. Epub 2011 Sep 19.

5.

Factors associated with the acquisition and severity of gestational listeriosis.

Suyemoto MM, Spears PA, Hamrick TS, Barnes JA, Havell EA, Orndorff PE.

PLoS One. 2010 Sep 27;5(9):e13000. doi: 10.1371/journal.pone.0013000.

6.

A Listeria monocytogenes mutant defective in bacteriophage attachment is attenuated in orally inoculated mice and impaired in enterocyte intracellular growth.

Spears PA, Suyemoto MM, Palermo AM, Horton JR, Hamrick TS, Havell EA, Orndorff PE.

Infect Immun. 2008 Sep;76(9):4046-54. doi: 10.1128/IAI.00283-08. Epub 2008 Jun 16.

7.

Host and bacterial factors in listeriosis pathogenesis.

Orndorff PE, Hamrick TS, Smoak IW, Havell EA.

Vet Microbiol. 2006 Apr 16;114(1-2):1-15. Epub 2006 Jan 18. Review.

PMID:
16414211
8.

A specific gene expression program triggered by Gram-positive bacteria in the cytosol.

McCaffrey RL, Fawcett P, O'Riordan M, Lee KD, Havell EA, Brown PO, Portnoy DA.

Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11386-91. Epub 2004 Jul 21.

9.

Influence of pregnancy on the pathogenesis of listeriosis in mice inoculated intragastrically.

Hamrick TS, Horton JR, Spears PA, Havell EA, Smoak IW, Orndorff PE.

Infect Immun. 2003 Sep;71(9):5202-9.

10.

Influence of extracellular bactericidal agents on bacteria within macrophages.

Hamrick TS, Diaz AH, Havell EA, Horton JR, Orndorff PE.

Infect Immun. 2003 Feb;71(2):1016-9.

11.

Characterization of Escherichia coli type 1 pilus mutants with altered binding specificities.

Harris SL, Spears PA, Havell EA, Hamrick TS, Horton JR, Orndorff PE.

J Bacteriol. 2001 Jul;183(13):4099-102.

12.

William E. Stewart II.

Marcus PI, Liebert MA, Friedman RM, Tovey MG, Havell EA, Sonnenfeld G, De Maeyer E, Gresser I.

J Interferon Cytokine Res. 2000 Oct;20(10):839-41. No abstract available.

PMID:
11054271
13.

Genetic characterization of Escherichia coli type 1 pilus adhesin mutants and identification of a novel binding phenotype.

Hamrick TS, Harris SL, Spears PA, Havell EA, Horton JR, Russell PW, Orndorff PE.

J Bacteriol. 2000 Jul;182(14):4012-21.

14.
15.

The mucosal phase of Listeria infection.

Havell EA, Beretich GR Jr, Carter PB.

Immunobiology. 1999 Dec;201(2):164-77. Review.

PMID:
10631565
16.
17.

Roles for tumor necrosis factor and gamma interferon in resistance to enteric listeriosis.

Beretich GR Jr, Carter PB, Havell EA.

Infect Immun. 1998 May;66(5):2368-73.

18.
19.
20.
21.
23.
24.
25.

Interleukin 1: an important mediator of host resistance against Pneumocystis carinii.

Chen W, Havell EA, Moldawer LL, McIntyre KW, Chizzonite RA, Harmsen AG.

J Exp Med. 1992 Sep 1;176(3):713-8.

27.

Type I IL-1 receptor blockade exacerbates murine listeriosis.

Havell EA, Moldawer LL, Helfgott D, Kilian PL, Sehgal PB.

J Immunol. 1992 Mar 1;148(5):1486-92.

PMID:
1531668
28.

Role of TNF in resistance to bacteria.

Havell EA.

Immunol Ser. 1992;56:341-63. Review. No abstract available.

PMID:
1550868
29.
30.

Tumor necrosis factor-independent IL-6 production during murine listeriosis.

Havell EA, Sehgal PB.

J Immunol. 1991 Jan 15;146(2):756-61.

PMID:
1987284
31.
33.
37.

Production of tumor necrosis factor during murine listeriosis.

Havell EA.

J Immunol. 1987 Dec 15;139(12):4225-31.

PMID:
3693903
39.
40.

Augmented induction of interferons during Listeria monocytogenes infection.

Havell EA.

J Infect Dis. 1986 May;153(5):960-9.

PMID:
3084667
41.
43.

The glycoprotein nature of murine gamma interferon.

Havell EA, Spitalny GL.

Arch Virol. 1984;80(2-3):195-207.

PMID:
6202280
44.

Two molecular weight species of murine gamma interferon.

Havell EA, Spitalny GL.

Virology. 1983 Sep;129(2):508-13.

PMID:
6414177
45.

Endotoxin-induced interferon synthesis in macrophage cultures.

Havell EA, Spitalny GL.

J Reticuloendothel Soc. 1983 May;33(5):369-80.

PMID:
6188828
46.

Production and characterization of anti-murine interferon-gamma sera.

Havell EA, Spitalny GL.

J Interferon Res. 1983;3(2):191-8.

PMID:
6409971
47.

Effect of interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells).

Rothermel CD, Byrne GI, Havell EA.

Infect Immun. 1983 Jan;39(1):362-70.

48.
49.

Effect of tunicamycin on the physical properties and antiviral activities of murine L cell interferon.

Havell EA, Carter WA.

Virology. 1981 Jan 15;108(1):80-6. No abstract available.

PMID:
6168096
50.

Antigenic properties of murine interferons from cells of non-lymphoid origin.

Havell EA, Spitalny GL.

Tex Rep Biol Med. 1981-1982;41:280-6. No abstract available.

PMID:
6184814

Supplemental Content

Loading ...
Support Center